Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

References 

1. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010 Mar 17;[Epub ahead of print.]
2. Rogers SN, Laher S, Overend L, Lowe D. Domain importance-rating using the UW-QOL questionnaire in patients treated by primary surgery for oral and oropharyngeal cancer. J Craniomaxillofac Surg. 2002;30:125–132
   • Abstract
   • Full-Text PDF (147 KB)
3. Chandu A, Smith AC, Rogers SN. Health-related quality of life in oral cancer: a review. J Oral Maxillofac Surg. 2006;64:495–502
   • Abstract
   • Full Text
   • Full-Text PDF (130 KB)
   • CrossRef
4. Rogers SN, Johnson IA, Lowe D. Xerostomia after treatment for oral and oropharyngeal cancer using the University of Washington saliva domain and a xerostomia-related quality-of-life scale. Int J Radiat Oncol Biol Phys. 2010;77:16–23
   • Abstract
   • Full Text
   • Full-Text PDF (124 KB)
   • CrossRef
5. Brennan MT, Elting LS, Spijkervet FLK. Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature. Support Care Cancer. 2010 Mar 20;[Epub ahead of print.]
6. Brown JS, Blackburn T, Woolgar JA, Lowe D, Rogers SN, Vaughan ED. A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with postoperative radiotherapy. Oral Oncol. 2007;43:764–773
   • Abstract
   • Full Text
   • Full-Text PDF (159 KB)
   • CrossRef
7. Bekiroglu F, Laycock R, Katre C, Lowe D, Rogers SN. Adjuvant radiotherapy and health-related quality of life of patients at intermediate risk of recurrence following primary surgery for oral squamous cell carcinoma. (personal communication-in preparation for submission).